Stealth BioTherapeutics (Stealth BioTherapeutics) ROCE % : -91.47% (As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Stealth BioTherapeutics's annualized ROCE % for the quarter that ended in Mar. 2022 was -91.47%.

Stealth BioTherapeutics ROCE % Historical Data

The historical data trend for Stealth BioTherapeutics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics ROCE % Chart

Stealth BioTherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

ROCE %

Get a 7-Day Free Trial

-331.32

-189.25

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
ROCE %	Get a 7-Day Free Trial															-177.12	-389.50	-91.45	-211.85	-91.47

Stealth BioTherapeutics ROCE % Calculation

Stealth BioTherapeutics's annualized ROCE % for the fiscal year that ended in Dec. 2021 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2021 )		(A: Dec. 2020 )		(A: Dec. 2021 )
	=	-51.285	/	( ( (35.848 - 21.049)	+	(50.226 - 10.828) )	/ 2 )
	=	-51.285	/	( (14.799	+	39.398)	/ 2 )
	=	-51.285	/	27.0985
	=	-189.25 %

Stealth BioTherapeutics's ROCE % of for the quarter that ended in Mar. 2022 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2022 )		(Q: Dec. 2021 )		(Q: Mar. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2022 )		(Q: Dec. 2021 )		(Q: Mar. 2022 )
	=	-30.38	/	( ( (50.226 - 10.828)	+	(36.915 - 9.889) )	/ 2 )
	=	-30.38	/	( ( 39.398	+	27.026 )	/ 2 )
	=	-30.38	/	33.212
	=	-91.47 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2022) EBIT data.

Stealth BioTherapeutics (NAS:MITO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Stealth BioTherapeutics ROCE % Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005

Website

https://www.stealthbt.com

Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.